SUVmax and SUVmean for each hot sphere when the Gaussian filter is changed. by Masakazu Tsujimoto (22339504)

Subjects:

Results of dose linearity. by Masakazu Tsujimoto (22339504)

Subjects:

SIINFEKL-specific CD8⁺ T cells treated with anti-CXCR3 decreased the polyfunctionality. by Camila Pontes Ferreira (6194006)

Comparison of baseline characteristics stratified by the occurrence of ISR > 50%. by Jae-Chan Ryu (2850581)

DataSheet1_Decreased consumption of natural rewards in rhesus monkeys with prolonged methamphetamine abstinence.pdf by Jiahui Zhou (6106628)

Elevated IDO activity in HD mouse brains is decreased by <i>ex-vivo</i> iron chelation. by David W. Donley (3111198)

“…</b> Striatal IDO activity is increased in N171-82Q HD mice and significantly decreased by <i>ex vivo</i> iron (III) chelation (50 μM deferoxamine). …”

Chlorinated Cubane-1,4-dicarboxylic Acids by Adéla Křížková (14551641)

Subjects:

Cells expressing nsP2 inefficiently present antigen and have decreased levels of cell surface MHC-I. by Brian C. Ware (8544672)

Molecular dynamics simulations of the three systems (MMP9-MOL000098, MMP9-MOL000354, MMP9-MOL000422) after 50 ns. by Lefei Yu (12274846)

Molecular dynamics simulations of the three systems (IL-6-MOL000098, IL-6-MOL000354, IL-6-MOL000422) after 50 ns. by Lefei Yu (12274846)

N1-specific anti-serum decreases replication of A(H1N1)pdm09 in HAE cells. by Anouk Smet (713884)

Results for fibrin dominant clots: (A) time to recanalize <i>in vitro</i> model; (B) relative clot reduction; (C) RBC release; (D) relative clot degradation rate. by Sandra Thalerová (11434762)

Subjects:

Transparent <i>in vitro</i> MCA model preparation. by Sandra Thalerová (11434762)

Subjects:

Complete data. by Sandra Thalerová (11434762)

Subjects:

Proposed concept of collaterals action: The collateral circulation lowered the pressure across the clot which resulted in lesser clot compaction and a subsequent easier clot distal... by Sandra Thalerová (11434762)

Subjects:

Initial RBC dominant clot compaction in the <i>in vitro</i> MCA model without and with collateral with alteplase applied at clinically relevant concentration (1.3 mg L^-1... by Sandra Thalerová (11434762)

Subjects:

Video of real-time recanalization of <i>in vitro</i> MCA model. by Sandra Thalerová (11434762)

Subjects:

Detailed representation of <i>in vitro</i> MCA model dimensions. by Sandra Thalerová (11434762)

Subjects:

Video of <i>in vitro</i> MCA model occlusion with RBC dominant clot. by Sandra Thalerová (11434762)

Subjects:

Histological analysis of <i>in vitro</i> blood clots. by Sandra Thalerová (11434762)

Subjects: